183 evolution "https:" "https:" "https:" "https:" "https:" "https:" "U.S" "St" "St" "St" positions at Nature Careers in Germany
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
development. It is one of the world's leading research institutions in its field and offers natural and social scientists from around the world an inspiring environment for excellent interdisciplinary research
-
We are seeking an experimental biologist to support the development of next-generation RNA-based precision therapies. The work is part of a core project within curATime (Cluster for Atherothrombosis
-
our publications here . Our team is at the forefront of bringing autologous cell replacement therapies with CRISPR-edited muscle stem cells towards the clinic (https://www.mdc-berlin.de/news/news/deep
-
data from the European XFEL facility at DESY. Project website: https://www.mpinat.mpg.de/628848/SM-Ultrafast-XRay-Diffraction Your profile Eligible candidates have strong skills in computational physics
-
with the IfSG before starting employment (currently: measles). General information on professorships, hiring processes, and the German academic system can be found here: https://uni-tuebingen.de/en
-
at both institutions offers exceptional opportunities for the development of new research concepts. Your responsibilities As director of the NIhK, you will be responsible for managing the natural sciences
-
science. The program complements the MICROSTAR initiative, forming the HUMAN–MICROSTAR Alliance — a unified framework bridging host- and microbe-focused infection biology. More details: https
-
framework bridging host- and microbe-focused infection biology. More details: https://www.helmholtz-hzi.de/en/research/research-program/human-microstar/
-
well as multifold training and support for PhD students in framework of ISAS and the Leibniz association Training and scientific development opportunities in an international environment and an excellent working
-
the development of scalable software tools and pipelines, potentially leveraging GPU/FPGA accelerators. Our aim is to build next-generation molecular atlases for chronic diseases and to improve patient